Dr Priyank Pankajkumar Shah, MD | |
1640 E Roosevelt Blvd, Monroe, NC 28112-4017 | |
(704) 226-0500 | |
(704) 226-0599 |
Full Name | Dr Priyank Pankajkumar Shah |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 16 Years |
Location | 1640 E Roosevelt Blvd, Monroe, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285946988 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
Novant Health Matthews Medical Center | Matthews, NC | Hospital |
Novant Health Mint Hill Medical Center | Charlotte, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Presbyterian Hospital | 1153231907 | 359 |
Novant Medical Group Inc | 1153234893 | 1996 |
Novant Health Matthews Medical Center Llc | 6406845247 | 56 |
Novant Health Mint Hill Medical Center, Llc | 8123374394 | 21 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | Novant Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | Novant Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306950282 PECOS PAC ID: 1153234893 Enrollment ID: O20040204001028 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | The Presbyterian Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | Novant Health Matthews Medical Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | Novant Health Mint Hill Medical Center, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063910404 PECOS PAC ID: 8123374394 Enrollment ID: O20181018000540 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Entity Name | Novant Health Ballantyne Medical Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760190607 PECOS PAC ID: 4880065143 Enrollment ID: O20230518003163 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Priyank Pankajkumar Shah, MD Po Box 60447, Charlotte, NC 28260-0447 Ph: (704) 226-0500 | Dr Priyank Pankajkumar Shah, MD 1640 E Roosevelt Blvd, Monroe, NC 28112-4017 Ph: (704) 226-0500 |
News Archive
The American Pain Society, www.americanpainsociety.org, today condemned the Trump Administration's proposed 19 percent cut in funding for the National Institutes of Health and warned that such a draconian budget reduction would devastate biomedical research in the United States unless Congress acted to prevent it.
Laboratory studies have shown that male mice who are exposed in the womb to bisphenol A, or BPA, a chemical compound found in some hard plastics and can linings, appear to be less masculine and less attractive to females once they mature. This raises controversies that human boys could be similarly affected. The findings were published Monday on the website of the journal Proceedings of the National Academy of Sciences.
Crossmatch, a leading provider of livescan enrollment and multi-factor authentication solutions, announced today that the company's Verifier Sentry handheld has been awarded the Biometric Identification Device of 2015 by Government Security News (GSN).
Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.
› Verified 4 days ago
Dr. Thomas Joseph Bice, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1969 Wellness Blvd, Monroe, NC 28110 Phone: 704-316-5775 Fax: 704-316-5815 | |
Rajiv Paudel, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Charles H Hoover Iii, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1420 E Franklin St, Monroe, NC 28112 Phone: 704-289-8427 Fax: 704-283-5522 | |
Pascale Anglade, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1663 Campus Park Dr, Suite D, Monroe, NC 28112 Phone: 704-291-2488 Fax: 704-283-0160 | |
Pawan Damodhar Sarda, M.D. Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 | |
Santhosh Reddy Devarapally, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Dr. James Wayne Roberts, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 |